Cardiovascular-Kidney-Metabolic (CKM) Health Initiative™
Advancing Cardiovascular-Kidney-Metabolic Health Through Collaboration
About the Initiative
The American Heart Association CKM Health Initiative™ harnesses collaboration between science and systems, clinicians and communities, data and decisions. Together, we are adapting care to meet the needs of patients with multiple diseases, supporting an integrated, intelligent model and focusing on outcomes that matter.
The Vision: From Science to Practice
Good CKM health becomes possible when science, practice and systems collaborate, driving innovation that puts patients first. CKM Health is grounded in evidence-based science — connecting groundbreaking research to real-world clinical decisions. The initiative translates scientific discovery into practice by:
- Leveraging data to identify opportunities for process improvement
- Implementing proven methods for interdisciplinary collaboration
- Supporting clinicians with peer-to-peer learning
- Including community organizations in care models to improve access to health resources
The CKM Health care model links science, people and places to improve lives.
About the Initiative
Why Now? Collaboration Is Our Most Powerful Tool for Change
Quality Improvement Consultation
Professional & patient-facing resources
Measurement & tracking support
Collaboration with peer sites locally & across the US
Recognition & model sharing opportunities
Project participation stipend
Interested? Get Connected.
There are many ways to engage with the CKM Health Initiative by the American Heart Association. Sign up to receive more information.
The American Heart Association's Cardiovascular-Kidney-Metabolic Health Initiative is made possible by Founding Sponsors Novo Nordisk and Boehringer Ingelheim, Supporting Sponsors Novartis Pharmaceuticals Corporation and Bayer, and Champion Sponsor DaVita.